ITMN Stock UPDATES Intermune Inc (ITMN) 73.45 09/02/2014 02:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intermune Inc (ITMN) 73.45 $ITMN

Four biotech takeover targets?
at Investor's Business Daily - Fri Aug 29, 5:58PM CDT
Following the news that Roche (RHHBY) is acquiring InterMune (ITMN) for $8.3 bil, other takeover talk has started to stir, leading to speculation that Achillion Pharmaceuticals (ACHN), Intercept Pharmaceuticals (ICPT), Puma Biotechnology (PBYI) and...

Top Performing Sector ETFs of August - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Aug 29, 1:00PM CDT
Few sector ETFs have performed exceptionally well this month and are leading the market higher.

4 Biotechs That Might Be Bought Soon
at Investor's Business Daily - Fri Aug 29, 10:53AM CDT
The recent announcement that Roche (RHHBY) will buy InterMune (ITMN) for $8.3 billion brought new life to M&A speculation in the biotech industry, which had been relatively neglected as the buzz focused on tax-inversion deals by biopharmaceutical...

Acquisitions, Appointment, and Vaccine Recommendations - Research Reports on InterMune, Amgen, Johnson & Johnson, Merck and Medtronic
PR Newswire - Thu Aug 28, 8:30AM CDT
Today, Analysts Review released its research reports regarding InterMune Inc. (NASDAQ: ITMN), Amgen, Inc. (NASDAQ: AMGN), Johnson & Johnson (NYSE: JNJ), Merck & Co., Inc. (NYSE: MRK) and Medtronic, Inc. (NYSE: MDT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6042-100free.

InterMune Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR Newswire - Wed Aug 27, 4:13PM CDT
Securities lawyers at Dunnam & Dunnam are investigating the board of InterMune (NASDAQ: ITMN) in connection with a buyout for only $74 per share. Concerned ITMN investors are encouraged to contact attorney Hamilton Lindley by clicking here.

INTERMUNE SHAREHOLDER ALERT - InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of InterMune, Inc. to Roche Holding AG
Business Wire - Wed Aug 27, 3:26PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of InterMune, Inc. (Nasdaq:ITMN) ("InterMune" in connection with the sale of the Company to Roche Holding AG.

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Aug 27, 9:32AM CDT
Roche's agreement to acquire InterMune has raised hopes for more such deals in the biotech sector.

INTERMUNE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating the Board of Directors of InterMune, Inc. (ITMN) in Relation to the Proposed Sale of the Company to Roche Holdings, Inc.
Business Wire - Wed Aug 27, 9:21AM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of InterMune, Inc. ("InterMune" or the "Company" (NasdaqGS:ITMN) for potential breaches of fiduciary duties in connection with the sale of the Company to Roche Holdings, Inc. for approximately $8.3 billion in cash. The Company's stockholders will receive $74.00 for each share of InterMune common stock they own.

Roche, InterMune a Strategic Play in Midst of Inversions
at The Street - Wed Aug 27, 8:19AM CDT
As more companies seek tax savings through inversions, strategic reasons still remain for drug company deals.

INVESTOR ALERT - InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of InterMune, Inc. to Roche Holding AG
Business Wire - Tue Aug 26, 5:58PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of InterMune, Inc. (Nasdaq:ITMN) ("InterMune" in connection with the sale of the Company to Roche Holding AG.

Roche Furthers Immunotherapy Program with SP142 Launch - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 5:22PM CDT
Roche (RHHBY) announced that Spring Bioscience, a member of the Roche Group, has launched its PD-L1 (SP142) rabbit monoclonal immunohistochemistry (IHC) antibody1.

Celgene, Gilead Lead Big Biotech Stock Movers
at Investor's Business Daily - Tue Aug 26, 4:55PM CDT
Big-cap biotechs moved in strong volume on the stock market today as Deutsche Bank added several to its short-term buy list, after Citi reported back from visits with medical experts. Celgene (CELG) hit a new high above 95 after Deutsche Bank analyst...

Stocks Rise As Biotechs Lead; Amazon To Buy Twitch
at Investor's Business Daily - Tue Aug 26, 3:58PM CDT
Stocks were moderately higher Monday with biotech stocks leading the way. The Nasdaq and the Dow Jones industrial average rose 0.4% and the S&P 500 gained 0.5%. After the close, Amazon (AMZN) announced it was paying $970 million to buy Twitch, a live...

INTERMUNE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Tue Aug 26, 12:36PM CDT
Rigrodsky & Long, P.A.:

Biotech ETFs Surge on InterMune-Roche Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Aug 26, 12:00PM CDT
The news of InterMune's acquisition by Roche has led to a rally in the biotech ETFs space.

Why InterMune (ITMN) Stock Is Gaining Today
at The Street - Tue Aug 26, 11:14AM CDT
InterMune (ITMN) shares are up on heavy trading, one day after the company agreed to be bought by Roche for $8.3 billion.

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of InterMune, Inc. and Its Board of Directors In Connection With the Sale of the Company to Roche Holding AG -- ITMN
PR Newswire - Tue Aug 26, 10:35AM CDT
Levi & Korsinsky is investigating the Board of Directors of InterMune, Inc. ("InterMune" or the "Company" (NASDAQ: ITMN) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Roche Holding AG.

3 Biotechs Surging Following InterMune Takeover - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 10:07AM CDT
InterMune 's (ITMN) impending acquisition by Roche (RHHBY) caused many mid-cap biotechs to rise.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORM Rejects Hafnia's No-Premium Merger Pitch Again

Updated Category News Views 112

A 19.8% shareholder heading for the exit can rattle a shipping stock before breakfast, and TORM has answered the noise with a flat refusal to pretend Hafnia's merger approach was good enough. The message from Hellerup on November 18 is unusually blunt: Hafnia made several conditional, all-share proposals, TORM saw no effective premium for control, and the board rejected...

Continue Reading
ETCO Targets the Unflashy Weak Link in Battery Storage

Updated Category News Views 38

A battery cabinet can look impressive right up until one lousy connection becomes the problem nobody budgeted for. ETCO Incorporated’s new lineup of standard and custom connectors and terminals goes after that unglamorous part of battery energy storage systems: the physical handoff points carrying power, grounding equipment, and tying auxiliary components together. It...

Continue Reading
Epsium's Inventory Pile Looms Over Weak First Half

Updated Category News Views 73

A warehouse full of bottles is not a balance-sheet fortress when buyers are backing away. Epsium Enterprise’s first-half 2026 report is a rough read: revenue collapsed 51.8% to $1.47 million, gross profit fell to $175,353, and cash slid to $612,761 at June 30. This is not a subtle slowdown. Macau’s premium Chinese-liquor market has been weak on both demand and...

Continue Reading
Pacific Surfliner Faces Thanksgiving Capacity Test

Updated Category News Views 76

Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...

Continue Reading
Knowles Expands Its Teacher Pipeline With 39 Fellows

Updated Category News Views 79

Thirty-Nine Teachers Is Not a Trivial Signal Thirty-nine new math and science teachers may not rattle public markets, but it says plenty about where the real strain sits in American education. The Knowles Teacher Initiative has named its 2026 Teaching Fellowship class, its largest ever, and the timing is dead serious: schools are still wrestling with recruiting and...

Continue Reading
Rokt's 164% Growth Shows Checkout Ads Have Real Muscle

Updated Category News Views 146

Checkout screens have become valuable real estate, and Rokt is planting a flag right in the middle of them. The New York ecommerce technology company landed on Deloitte's 2026 Technology Fast 500 after posting 164% revenue growth from 2022 through 2025. That is a meaningful number, not decorative corporate confetti, especially in a digital-ad market where plenty of...

Continue Reading
PARRIS Partners Earn 2026 Plaintiff Lawyer Recognition

Updated Category News Views 49

A $58.4 million jury number can make a courtroom sound like a slot machine, until the final settlement lands at $21 million. That gap is the part people ought to stare at before getting carried away by another plaintiff-lawyer honor roll. The Daily Journal has named PARRIS Law Firm partners Alexander R. Wheeler and Khail A. Parris to its 2026 Top Plaintiff Lawyers special...

Continue Reading
Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 165

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
CloudBackend's €6.6M Test: Can Vibe Code Become SaaS?

Updated Category News Views 171

A prototype is cheap theatre; keeping it alive after customers arrive is where the bill lands. CloudBackend has raised €6.6 million to attack that unglamorous, absolutely vital stretch between an AI-made app and an actual software business. The round is led by Carl-Henric Svanberg's family office, while existing backer M2 Asset Management increased its stake. That is a...

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 138

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading

Top 5 Most Recently Viewed Articles

Artisan Partners Asset Management's Q2 Performance and Highlights

Updated Category News Views 124

Artisan Partners Asset Management Inc. Reports Strong Q2 Performance Artisan Partners Asset Management Inc. (NYSE: APAM) recently showcased its financial success for the quarter ending June 30, 2025. The Company, renowned for its investment strategies, declared a quarterly dividend as part of its results presentation. This reflects Artisan's commitment to providing value...

Continue Reading
LVMH Reports Recent Share Transactions and Market Activity

Updated Category News Views 240

Understanding LVMH's Share Transactions Recently, LVMH Moët Hennessy Louis Vuitton disclosed share transactions conducted between exciting dates. This information was provided to the regulatory body, ensuring transparency for investors and industry stakeholders alike. As one of the leading companies in the luxury goods sector, LVMH’s transactions are always...

Continue Reading
Dynavax Technologies to Share Insights at Healthcare Conference

Updated Category News Views 160

Dynavax's Upcoming Participation in Healthcare Conference Dynavax Technologies Corporation (Nasdaq: DVAX), a prominent player in the biopharmaceutical landscape, is set to take part in a pivotal fireside chat at the 8th Annual Evercore Healthcare Conference. This insightful event will take place on an upcoming Tuesday at 2:10 p.m. ET. Investors and healthcare stakeholders...

Continue Reading
Growing Demand for 3D Surveillance Cameras by 2030

Updated Category News Views 301

The Growing Market for 3D Surveillance Cameras The global 3D surveillance camera market is on the brink of substantial growth, with forecasts indicating it could reach an impressive $7.92 billion by 2030. This surge is primarily fueled by increased investments in defense and public safety initiatives around the world. A key factor in this trend is the rising use of 3D...

Continue Reading
LVMH Stock Upgrade by BofA Signals Strong Growth Ahead

Updated Category News Views 317

LVMH Receives Positive Rating Upgrade from Bank of America Recently, Bank of America made headlines by upgrading LVMH shares to a Buy rating, moving it from a previous Neutral stance. This upgrade places the renowned luxury goods giant on its prestigious Europe 1 list of preferred investment ideas. Revised Price Targets Indicate Strong Potential The ratings agency has...

Continue Reading